Assessment of Grazax® Treatment Compliance
NCT00293046
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
500
Enrollment
INDUSTRY
Sponsor class
Conditions
Allergy
Interventions
BIOLOGICAL:
ALK Grass tablet - use of compliance device
Sponsor
ALK-Abelló A/S